Company: AILIM
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001002910-25-000129
Chunk: 74

Company: Ameren Illinois Co
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 74
---
 sheet. Any earnings or losses related to these investments are included in “Other Income, Net” on Ameren’s consolidated statement of income and comprehensive income. Ameren is not the primary beneficiary of these investments because it does not have the power to direct matters that most significantly affect the activities of these variable interest entities. As of September 30, 2025, Ameren’s maximum exposure to loss related to these variable interest entities is limited to the investment in these partnerships of $60 million plus associated outstanding funding commitments of $31 million.COLIAmeren (parent) and Ameren Illinois have COLI, which is recorded at the net cash surrender value. The net cash surrender value is the amount that can be realized under the insurance policies at the balance sheet date. As of September 30, 2025, the cash surrender value of COLI at Ameren and Ameren Illinois was $220 million (December 31, 2024 – $260 million) and $124 million (December 31, 2024 – $118 million), respectively, while total borrowings against the policies were $117 million (December 31, 2024 – $110 million) at both Ameren and Ameren Illinois. Ameren and Ameren Illinois have the right to offset the borrowings against the cash surrender value of the policies and, consequently, present the net asset in “Other assets” on their respective balance sheets. The net cash surrender value of Ameren’s COLI is affected by the investment performance of a separate account in which Ameren holds a beneficial interest.Accounting and Reporting DevelopmentsImprovements to the Accounting for Internal-Use SoftwareIn September 2025, the FASB issued authoritative guidance that made targeted improvements to the accounting for internal-use software. The guidance requires an entity to capitalize internal-use software costs when management has authorized and committed to funding the software project, and it is probable that the project will be completed and the software will be used to perform its intended function. This guidance will be effective for the Ameren Companies in the first quarter of 2028. We are currently assessing the impacts of this guidance on our results of operations, financial position, and liquidity.

NOTE 2 – RATE AND REGULATORY MATTERS

Below is a summary of updates to significant regulatory proceedings and related legal proceedings. See Note 2 – Rate and Regulatory Matters under Part II, Item 8, of the Form 10-K for additional information and a summary